SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-028240
Filing Date
2023-08-08
Accepted
2023-08-08 16:46:33
Documents
53
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rgls-20230630.htm   iXBRL 10-Q 1220503
2 EX-10.2 ex102-klassenprestonemploy.htm EX-10.2 145591
3 EX-10.4 ex104-regulusxnoticeofchan.htm EX-10.4 31634
4 EX-31.1 ex-311x20230630.htm EX-31.1 9692
5 EX-31.2 ex-312x20230630.htm EX-31.2 9683
6 EX-32.1 ex-321x20230630.htm EX-32.1 9547
12 EX-10.4 oxford-q2ximage.gif GRAPHIC 5732
  Complete submission text file 0001628280-23-028240.txt   5307929

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rgls-20230630.xsd EX-101.SCH 30918
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rgls-20230630_cal.xml EX-101.CAL 53946
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rgls-20230630_def.xml EX-101.DEF 191137
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rgls-20230630_lab.xml EX-101.LAB 463642
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rgls-20230630_pre.xml EX-101.PRE 288329
47 EXTRACTED XBRL INSTANCE DOCUMENT rgls-20230630_htm.xml XML 540450
Mailing Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121
Business Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35670 | Film No.: 231152171
SIC: 2834 Pharmaceutical Preparations